Agios Pharmaceuticals
AGIO
#5079
Rank
NZ$2.75 B
Marketcap
NZ$47.28
Share price
-1.73%
Change (1 day)
-40.38%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: NZ$2.75 Billion

As of December 2025 Agios Pharmaceuticals has a market cap of NZ$2.75 Billion. This makes Agios Pharmaceuticals the world's 5079th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$2.75 B-18.36%
2024NZ$3.37 B71.6%
2023NZ$1.96 B-19.01%
2022NZ$2.43 B-7.02%
2021NZ$2.61 B-37.16%
2020NZ$4.15 B-14.24%
2019NZ$4.84 B21.18%
2018NZ$4.00 B1.97%
2017NZ$3.92 B55.06%
2016NZ$2.53 B-29.21%
2015NZ$3.57 B-32.6%
2014NZ$5.30 B483.39%
2013NZ$0.90 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Agios Pharmaceuticals was reported to be:

NZ$2.80 Billion
by Nasdaq info icon info icon
NZ$2.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
NZ$2.13 B-22.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$19.14 B 594.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$250.37 B 8,980.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$17.67 B 541.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.59 B 6,050.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
NZ$1.567 T 56,735.31%๐Ÿ‡บ๐Ÿ‡ธ USA